These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1392844)

  • 1. Growth hormone and recurrence of tumour.
    Hindmarsh P; Brook CG
    BMJ; 1992 Jul; 305(6847):254. PubMed ID: 1392844
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone and tumour recurrence.
    Ogilvy-Stuart AL; Ryder WD; Gattamaneni HR; Clayton PE; Shalet SM
    BMJ; 1992 Jun; 304(6842):1601-5. PubMed ID: 1628087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth impairment following treatment for childhood brain tumours.
    Shalet SM; Clayton PE; Price DA
    Acta Paediatr Scand Suppl; 1988; 343():137-45. PubMed ID: 3057805
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of tumor recurrence and growth hormone therapy.
    Rivas-Crespo MF; Gutiérrez-Puebla A; Antuña-García MJ; Crespo-Hernández M
    Acta Paediatr; 1995 Oct; 84(10):1102. PubMed ID: 8563218
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement.
    Kiltie AE; Collins CD; Gattamaneni HR; Shalet SM
    Med Pediatr Oncol; 1997 Jul; 29(1):41-4. PubMed ID: 9142205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications of treatment with growth hormone].
    Czernichow P
    Arch Pediatr; 1996; 3 Suppl 1():156s-157s. PubMed ID: 8796000
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour occurrence and recurrence.
    Ogilvy-Stuart AL; Shalet SM
    Horm Res; 1992; 38 Suppl 1():50-5. PubMed ID: 1295813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of growth hormone in children surviving cancer.
    Moshang T
    Med Pediatr Oncol; 1998 Sep; 31(3):170-2. PubMed ID: 9722900
    [No Abstract]   [Full Text] [Related]  

  • 9. Does growth hormone increase the risk of malignancies?
    Ritzén EM
    Horm Res; 1993; 39(3-4):99-101. PubMed ID: 8262484
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience.
    Moshang T; Rundle AC; Graves DA; Nickas J; Johanson A; Meadows A
    J Pediatr; 1996 May; 128(5 Pt 2):S4-7. PubMed ID: 8627468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone therapy in boy with panhypopituitarism may induce pilomatricoma recurrence: case report.
    Oswiecimska JM; Ziora KT; Ziora KN; Pindycka-Piaszczynska M; Zajecki W; Pikiewicz-Koch A; Stojewska M
    Neuro Endocrinol Lett; 2008 Feb; 29(1):51-4. PubMed ID: 18283258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of growth hormone treatment in patients previously treated for cancer.
    Chemaitilly W; Robison LL
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):785-92. PubMed ID: 23099270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation and growth hormone deficiency.
    Burrows AW; Hockaday TD
    Br Med J; 1977 Oct; 2(6091):893-4. PubMed ID: 922343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of cranio-spinal radiotherapy on growth].
    Pombo M; Couce ML; Devesa J; Couselo JM
    An Esp Pediatr; 1992; 37 Suppl 51():4-7. PubMed ID: 1492727
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone treatment of children with brain tumors and risk of tumor recurrence.
    Swerdlow AJ; Reddingius RE; Higgins CD; Spoudeas HA; Phipps K; Qiao Z; Ryder WD; Brada M; Hayward RD; Brook CG; Hindmarsh PC; Shalet SM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4444-9. PubMed ID: 11134091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors.
    Jostel A; Mukherjee A; Hulse PA; Shalet SM
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):698-705. PubMed ID: 15943832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment and cancer risk.
    Banerjee I; Clayton PE
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):247-63. PubMed ID: 17336744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
    Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eternal vigilance--mortality in children with growth hormone deficiency.
    Hintz RL
    J Clin Endocrinol Metab; 1996 May; 81(5):1691-2. PubMed ID: 8626816
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
    Hayward R
    Childs Nerv Syst; 2002 Nov; 18(11):565; author reply 566. PubMed ID: 12420115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.